|
Market Closed -
Toronto S.E.
22:42:34 20/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 31.43 CAD | +2.01% |
|
+5.43% | +24.28% |
| 10-19 | Gilead Sciences, Inc. Presents New Findings From Its HIV And Antiviral Research And Development Programs At IDWeek 2026 | CI |
| 10-19 | Gilead's pill succeeds in mid-stage bowel disease trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.49% | +10.04% | +11.34% | +11.92% | +19.45% | +58.68% | +119.56% | +426.69% | +1,530.25% | 1,144B | |
| +2.19% | +4.32% | -3.94% | +4.24% | +25.32% | +33.88% | +69.52% | +58.36% | +125.79% | 625B | |
| +2.26% | +5.37% | +9.52% | +14.09% | +26.52% | +24.57% | +97.69% | +166.65% | +368.07% | 511B | |
| +0.14% | +5.10% | +6.85% | +16.78% | +18.77% | +38.82% | +64.09% | +8.94% | +67.80% | 377B | |
| +3.25% | +4.45% | +0.97% | +19.21% | +40.89% | +71.80% | +44.44% | +82.93% | +139.50% | 366B | |
| +0.17% | +3.20% | +8.99% | +0.83% | +15.49% | +21.06% | +49.80% | +63.22% | +69.00% | 291B | |
| +0.13% | +2.67% | +0.54% | +1.09% | -8.43% | +1.23% | +25.03% | +42.48% | +155.01% | 262B | |
| +3.29% | +6.32% | +13.82% | +20.53% | +34.11% | +44.71% | +57.43% | +109.36% | +171.79% | 237B | |
| +2.25% | +5.81% | +4.26% | +17.49% | +27.51% | +27.13% | +101.17% | +134.09% | +110.62% | 194B | |
| -0.47% | +1.62% | +0.04% | -19.73% | -20.03% | -26.72% | -61.87% | -22.11% | +83.43% | 174B | |
| +2.28% | +6.13% | +8.86% | +21.66% | +20.92% | +21.95% | -1.76% | -29.65% | -7.47% | 172B | |
| +2.53% | +6.07% | +1.24% | +7.11% | +13.52% | +22.80% | +42.22% | +177.45% | +520.66% | 130B | |
| +4.84% | +8.84% | -2.19% | +2.53% | +14.35% | +41.50% | +9.25% | +6.22% | +22.48% | 126B | |
| +1.95% | +7.09% | +17.78% | +23.89% | +25.58% | +30.76% | +127.49% | +399.84% | +536.07% | 120B | |
| +0.27% | +3.14% | -1.99% | -1.06% | +2.66% | +13.83% | +28.08% | +6.21% | -9.65% | 100B | |
| -0.05% | +2.35% | -1.45% | -4.22% | -11.13% | -14.81% | -25.23% | -12.44% | +6.23% | 99.04B | |
| +6.69% | +11.94% | +57.15% | +306.93% | +720.89% | +788.69% | +201.09% | -27.31% | - | 96.65B | |
| +3.25% | +7.22% | +2.88% | +20.13% | +4.61% | +40.00% | -0.12% | +43.50% | +117.51% | 80.63B | |
| +0.44% | +3.56% | +10.82% | +9.46% | +19.86% | +28.01% | +1.45% | -27.75% | +48.80% | 71.51B | |
| Average | +1.19% | +5.37% | +7.66% | +24.89% | +52.15% | +66.73% | +49.97% | +84.56% | +225.33% | 272.51B | |
| Weighted average by Cap. | +0.95% | +4.99% | +6.74% | +15.74% | +32.21% | +49.54% | +68.70% | +151.88% | +468.03% |
- Stock Market
- Stocks
- GILD Stock
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
